Small molecules that inhibit Notch signaling.

Area of Science:

• Molecular Biology
• Cell Signaling
• Drug Discovery

Background:

• Notch signaling is vital for bodily processes and implicated in cancers.
• Proteolytic processing of Notch receptors is key to signal transduction.
• Gamma-secretase (γ-secretase) mediates the final Notch cleavage step.

Purpose of the Study:

• To review commonly used γ-secretase inhibitors (GSIs) in Notch signaling research.
• To discuss the advantages and disadvantages of existing GSIs.
• To highlight the need for selective GSIs for improved therapeutic applications.

Main Methods:

• Literature review of γ-secretase inhibitors (GSIs).
• Analysis of GSI applications in Notch signaling studies.
• Discussion of GSI selectivity and potential for drug development.

Main Results:

• GSIs are drug-like compounds optimized for γ-secretase, with some in clinical trials.
• Nonselective GSIs can inhibit Notch cleavage, offering therapeutic avenues.
• The existence of multiple Notch receptors and γ-secretase proteases complicates GSI specificity.

Conclusions:

• Existing GSIs are valuable tools for modulating Notch signaling.
• Further screening of GSIs for selectivity towards specific Notch receptors and γ-secretases is warranted.
• Developing selective GSIs could lead to safer and more effective cancer therapies.